Francis Yao, MD
Professor
Medicine
School of Medicine

Dr. Francis Yao is a gastroenterologist who serves as medical director of the UCSF Liver Transplant Program. He also directs the UCSF Liver Transplant Outreach and Community Liaison Program. In his research, Yao is interested in liver cancer treatment, particularly as related to liver transplants. He has contributed to important publications in this area. His other research interests include hepatitis B infection and outcomes for patients undergoing liver transplantation.

Education & Training

Show all (3) Hide

• Fellowship Gastroenterology Stanford Hospital and Clinics 1993
• Residency Internal Medicine Stanford Hospital and Clinics 1990
• Albert Einstein College of Medicine 1987

Websites

Show all (1) Hide

• Clinical Profile at UCSF Medical Center (ucsfhealth.org)

Publications (114)

Top publication keywords:
Resource AllocationCarcinoma, HepatocellularNeoplasm Recurrence, LocalTissue and Organ ProcurementTumor BurdenChemoembolization, Therapeuticalpha-FetoproteinsWaiting ListsLiver NeoplasmsLiver TransplantationPatient SelectionPatient DropoutsEnd Stage Liver DiseaseNeoplasm StagingHealth Care Rationing

• AFP-L3 and DCP strongly predict early hepatocellular carcinoma recurrence after liver transplantation.
  Journal of hepatology 2023 Norman JS, Li PJ, Kotwani P, Shui AM, Yao F, Mehta N
• Downstaging hepatocellular carcinoma before liver transplantation: A multicenter analysis of the "all-comers" protocol in the Multicenter Evaluation of Reduction in Tumor Size before Liver Transplantation (MERITS-LT) consortium.
  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2023 Natarajan B, Tabrizian P, Hoteit M, Frenette C, Parikh N, Ghaziani T, Dhanasekaran R, Guy J, Shui A, Florman S, Yao FY, Mehta N
• Refining the approach to down-staging of HCC prior to liver transplantation: Patient selection, loco-regional treatments, and systemic therapies.
  Hepatology (Baltimore, Md.) 2023 Mehta N, Kelley RK, Yao FY
• AFP-L3 and DCP are superior to AFP in predicting waitlist dropout in HCC patients: Results of a prospective study.
  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2023 Mehta N, Kotwani P, Norman J, Shui A, Li PJ, Saxena V, Chan W, Yao FY
• Alpha-fetoprotein slope over 7.5 ng/ml over 3 months before liver transplantation for hepatocellular carcinoma predicts recurrence even after controlling for alpha-fetoprotein at liver transplantation.
  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2023 Giard JM, Dodge JL, Yao FY, Mehta N

Show all (109 more) Hide

• National Experience on Waitlist Outcomes for Down-Staging of Hepatocellular Carcinoma: High Dropout Rate in All-Comers.
  Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2022 Huang AC, Dodge JL, Yao FY, Mehta N
• National experience with living donor liver transplantation for hepatocellular carcinoma.
  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2022 Silverstein J, Yao FY, Grab JD, Braun HJ, Roberts J, Dodge JL, Mehta N
• Lower Alpha-Fetoprotein Threshold of 500 ng/mL for Liver Transplantation May Improve Posttransplant Outcomes in Patients With Hepatocellular Carcinoma.
  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2022 Goldman ML, Zhou K, Dodge JL, Yao F, Mehta N
• The Impact of Median Model for End-Stage Liver Disease at Transplant Minus 3 National Policy on Waitlist Outcomes in Patients With and Without Hepatocellular Carcinoma.
  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2021 Bernards S, Hirose R, Yao FY, Jin C, Dodge JL, Huang CY, Mehta N
• Review of Liver Transplantation in Patients With Hepatocellular Carcinoma.
  Gastroenterology & hepatology 2021 Yao F
• Sex-based Disparities in Hepatocellular Carcinoma Recurrence After Liver Transplantation.
  Transplantation 2021 Cullaro G, Rubin J, Mehta N, Yao F, Verna EC, Lai JC
• Liver Transplantation After Downstaging of Hepatocellular Carcinoma With Portal Vein Tumor Thrombus Using Yttrium-90 Radioembolization: Pipe Dream or Reality?
  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2021 Mehta N, Yao FY
• Downstaging Outcomes for Hepatocellular Carcinoma: Results From the Multicenter Evaluation of Reduction in Tumor Size before Liver Transplantation (MERITS-LT) Consortium.
  Gastroenterology 2021 Mehta N, Frenette C, Tabrizian P, Hoteit M, Guy J, Parikh N, Ghaziani TT, Dhanasekaran R, Dodge JL, Natarajan B, Holzner ML, Frankul L, Chan W, Fobar A, Florman S, Yao FY
• Neutrophil-to-Lymphocyte Ratio Predicts High-Risk Explant Features and Waitlist Survival But Is Not Independently Associated With Recurrence or Survival Following Liver Transplantation for Hepatocellular Carcinoma.
  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2021 Harding-Theobald E, Yao FYK, Mehta N
• Hepatic Toxicity After Selective Chemoembolization Is Associated With Decreased Survival Among Patients With Hepatocellular Carcinoma.
  AJR. American journal of roentgenology 2021 Lokken RP, Kerlan RK, Chung YC, Chen YF, Mehta NJ, Yao FY, Fidelman N
• Disseminated Legionella micdadei infection in a liver transplant patient presenting as pulmonary nodules and a laryngeal lesion.
  Transplant infectious disease : an official journal of the Transplantation Society 2021 Bond AR, Bainbridge E, Doernberg SB, Babik JM, Miller S, Khanafshar E, Henry T, David A, Russell M, Brandman D, Sherman CB, Yao F, Fung M
• DCP and AFP-L3 Are Complementary to AFP in Predicting High-Risk Explant Features: Results of a Prospective Study.
  Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2021 Kotwani P, Chan W, Yao F, Mehta N
• The Key Role of Staging Definitions for Assessment of Downstaging for Hepatocellular Carcinoma.
  Seminars in liver disease 2021 Yao FY, Fidelman N, Mehta N
• Reply.
  Hepatology (Baltimore, Md.) 2020 Mehta N, Yao FY
• A novel waitlist dropout score for hepatocellular carcinoma - identifying a threshold that predicts worse post-transplant survival.
  Journal of hepatology 2020 Mehta N, Dodge JL, Roberts JP, Yao FY
• CON: Portal Vein Thrombosis Does Not Impact Liver Transplantation Outcomes.
  Clinical liver disease 2020 Sherman C, Syed S, Gardner J, Yao FY
• COVID-19 and Abdominal Transplant: A Stepwise Approach to Practice During Pandemic Conditions.
  Transplantation 2020 Syed SM, Gardner J, Roll G, Webber A, Mehta N, Shoji J, Adelmann D, Niemann C, Braun HJ, Mello A, Yao F, Posselt A, Kang SM, Hirose R, Roberts J, Feng S, Ascher N, Stock P, Freise C
• Hepatocellular Carcinoma Demonstrates Heterogeneous Growth Patterns in a Multicenter Cohort of Patients With Cirrhosis.
  Hepatology (Baltimore, Md.) 2020 Rich NE, John BV, Parikh ND, Rowe I, Mehta N, Khatri G, Thomas SM, Anis M, Mendiratta-Lala M, Hernandez C, Odewole M, Sundaram LT, Konjeti VR, Shetty S, Shah T, Zhu H, Yopp AC, Hoshida Y, Yao FY, …
• Surveillance for HCC After Liver Transplantation: Increased Monitoring May Yield Aggressive Treatment Options and Improved Postrecurrence Survival.
  Transplantation 2020 Lee DD, Sapisochin G, Mehta N, Gorgen A, Musto KR, Hajda H, Yao FY, Hodge DO, Carter RE, Harnois DM
• Effect of Nonalcoholic Fatty Liver Disease and Metabolic Risk Factors on Waitlist Outcomes in Patients With Hepatocellular Carcinoma.
  Transplantation direct 2020 Weinfurtner K, Dodge JL, Yao FYK, Mehta N
• Donation After Circulatory Death Is Associated With Similar Posttransplant Survival in All but the Highest-Risk Hepatocellular Carcinoma Patients.
  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2020 Silverstein J, Roll G, Dodge JL, Grab JD, Yao FY, Mehta N
• Bacchus Listed for a Liver Transplant: Comment.
  Anesthesiology 2020 Kronish K, Freise CE, Yao FY
• Liver Transplantation for Hepatocellular Carcinoma. Working Group Report from the ILTS Transplant Oncology Consensus Conference.
  Transplantation 2020 Mehta N, Bhangui P, Yao FY, Mazzaferro V, Toso C, Akamatsu N, Durand F, Ijzermans J, Polak W, Zheng S, Roberts JP, Sapisochin G, Hibi T, Kwan NM, Ghobrial M, Soin A
• Unfair Advantages for Hepatocellular Carcinoma Patients Listed for Liver Transplant in Short-Wait Regions Following 2015 Hepatocellular Carcinoma Policy Change.
  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2020 Brondfield MN, Dodge JL, Hirose R, Heimbach J, Yao FY, Mehta N
• Liver transplantation for hepatocellular carcinoma: Management after the transplant.
  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2019 Verna EC, Patel YA, Aggarwal A, Desai AP, Frenette C, Pillai AA, Salgia R, Seetharam A, Sharma P, Sherman C, Tsoulfas G, Yao FY
• National Experience on Down-Staging of Hepatocellular Carcinoma Before Liver Transplant: Influence of Tumor Burden, Alpha-Fetoprotein, and Wait Time.
  Hepatology (Baltimore, Md.) 2019 Mehta N, Dodge JL, Grab JD, Yao FY
• REPLY.
  Hepatology (Baltimore, Md.) 2019 Mehta N, Dodge JL, Yao FY
• Comparison of Liver Transplant Wait-List Outcomes Among Patients With Hepatocellular Carcinoma With Public vs Private Medical Insurance.
  JAMA network open 2019 Gutin L, Yao F, Dodge JL, Grab J, Mehta N
• Prospective Phase II trial of drug-eluting bead chemoembolization for liver transplant candidates with hepatocellular carcinoma and marginal hepatic reserve.
  Journal of hepatocellular carcinoma 2019 Fidelman N, Johanson C, Kohi MP, Kolli KP, Kohlbrenner RM, Lehrman ED, Taylor AG, Kelley RK, Yao FY, Roberts JP, Kerlan RK
• Noninvasive estimation of pulmonary vascular resistance improves portopulmonary hypertension screening in liver transplant candidates.
  Clinical transplantation 2019 DesJardin JT, Manicardi M, Svetlichnaya Y, Kolaitis NA, Papolos AI, Selby VN, Zier LS, Klein L, Aras MA, Yao FY, Roberts JP, De Marco T
• Are There Upper Limits in Tumor Burden for Down-Staging of Hepatocellular Carcinoma to Liver Transplant? Analysis of the All-Comers Protocol.
  Hepatology (Baltimore, Md.) 2019 Sinha J, Mehta N, Dodge JL, Poltavskiy E, Roberts J, Yao F
• Predictors of low risk for dropout from the liver transplant waiting list for hepatocellular carcinoma in long wait time regions: Implications for organ allocation.
  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2019 Mehta N, Dodge JL, Hirose R, Roberts JP, Yao FY
• What Are the Optimal Liver Transplantation Criteria for Hepatocellular Carcinoma?
  Clinical liver disease 2019 Mehta N, Yao FY
• Alpha-Fetoprotein Decrease from > 1,000 to < 500 ng/mL in Patients with Hepatocellular Carcinoma Leads to Improved Posttransplant Outcomes.
  Hepatology (Baltimore, Md.) 2019 Mehta N, Dodge JL, Roberts JP, Hirose R, Yao FY
• Distinguishing Tumor From Bland Portal Vein Thrombus in Liver Transplant Candidates With Hepatocellular Carcinoma: the A-VENA Criteria.
  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2019 Sherman CB, Behr S, Dodge JL, Roberts JP, Yao FY, Mehta N
• The mRECIST Classification Provides Insight into Tumor Biology for Patients With Hepatocellular Carcinoma Awaiting Liver Transplantation.
  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2019 Lee DD, Samoylova M, Mehta N, Musto KR, Roberts JP, Yao FY, Harnois DM
• Screening for Hepatocellular Carcinoma to Improve Cancer-Related Mortality: Looking Behind When We Should Be Looking Ahead.
  Gastroenterology 2018 Mehta N, Monto A, Yao FY
• Multicenter validation of a score to predict prognosis after the development of HCC recurrence following liver transplantation.
  HPB : the official journal of the International Hepato Pancreato Biliary Association 2018 Goldaracena N, Mehta N, Scalera I, Sposito C, Atenafu EG, Yao FY, Muiesan P, Mazzaferro V, Sapisochin G
• Increasing Liver Transplantation Wait-List Dropout for Hepatocellular Carcinoma With Widening Geographical Disparities: Implications for Organ Allocation.
  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2018 Mehta N, Dodge JL, Hirose R, Roberts JP, Yao FY
• Predictors of Ultrasound Failure to Detect Hepatocellular Carcinoma.
  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2018 Samoylova ML, Mehta N, Roberts JP, Yao FY
• Direct-acting antivirals do not increase the risk of hepatocellular carcinoma recurrence after local-regional therapy or liver transplant waitlist dropout.
  Hepatology (Baltimore, Md.) 2018 Huang AC, Mehta N, Dodge JL, Yao FY, Terrault NA
• Alpha-Fetoprotein Slope >7.5 ng/mL per Month Predicts Microvascular Invasion and Tumor Recurrence After Liver Transplantation for Hepatocellular Carcinoma.
  Transplantation 2018 Giard JM, Mehta N, Dodge JL, Roberts JP, Yao FY
• History of Marijuana Use Does Not Affect Outcomes on the Liver Transplant Waitlist.
  Transplantation 2018 Kotwani P, Saxena V, Dodge JL, Roberts J, Yao F, Hameed B
• Living donor liver transplantation for hepatocellular carcinoma: To expand (beyond Milan) or downstage (to Milan)?
  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2018 Mehta N, Yao FY
• Validation of the prognostic power of the RETREAT score for hepatocellular carcinoma recurrence using the UNOS database.
  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2017 Mehta N, Dodge JL, Roberts JP, Yao FY
• Con: Treating hepatitis C virus With direct-acting antivirals: Fear not the perceived threat of hepatocellular carcinoma.
  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2017 Mehta N, Yao FY
• Excellent Outcomes of Liver Transplantation Following Down-Staging of Hepatocellular Carcinoma to Within Milan Criteria: A Multicenter Study.
  Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2017 Mehta N, Guy J, Frenette CT, Dodge JL, Osorio RW, Minteer WB, Roberts JP, Yao FY
• Misdiagnosis of hepatocellular carcinoma in patients receiving no local-regional therapy prior to liver transplant: An analysis of the Organ Procurement and Transplantation Network explant pathology form.
  Clinical transplantation 2017 Mehta N, Dodge JL, Roberts JP, Hirose R, Yao FY
• Wait Time of Less Than 6 and Greater Than 18 Months Predicts Hepatocellular Carcinoma Recurrence After Liver Transplantation: Proposing a Wait Time "Sweet Spot".
  Transplantation 2017 Mehta N, Heimbach J, Lee D, Dodge JL, Harnois D, Burns J, Sanchez W, Roberts JP, Yao FY
• Liver transplantation recipients with nonalcoholic steatohepatitis have lower risk hepatocellular carcinoma.
  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2017 Lewin SM, Mehta N, Kelley RK, Roberts JP, Yao FY, Brandman D
• Validation of a Risk Estimation of Tumor Recurrence After Transplant (RETREAT) Score for Hepatocellular Carcinoma Recurrence After Liver Transplant.
  JAMA oncology 2017 Mehta N, Heimbach J, Harnois DM, Sapisochin G, Dodge JL, Lee D, Burns JM, Sanchez W, Greig PD, Grant DR, Roberts JP, Yao FY
• Transarterial Radioembolization for Hepatocellular Carcinoma: Who, When… and Y(90)?
  Gastroenterology 2016 Mehta N, Yao FY
• Reply.
  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2016 Mehta N, Yao FY
• Increased hepatocellular carcinoma recurrence in women compared to men with high alpha fetoprotein at liver transplant.
  Annals of hepatology 2016 Sarkar M, Dodge JL, Roberts JP, Terrault N, Yao F, Mehta N
• Lack of benefits of mammalian target of rapamycin inhibitor in patients transplanted for hepatocellular carcinoma: Is this the end of the story?
  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2016 Mehta N, Roberts JP, Yao FY
• Hepatocellular cancer as indication for liver transplantation: pushing beyond Milan.
  Current opinion in organ transplantation 2016 Mehta N, Yao FY
• Nucleos(t)ide analogs reduce the risk of hepatitis B-associated hepatocellular carcinoma: A can't miss proposition?
  Hepatology (Baltimore, Md.) 2016 Mehta N, Yao FY
• Intention to treat outcome of T1 hepatocellular carcinoma with the "wait and not ablate" approach until meeting T2 criteria for liver transplant listing.
  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2016 Mehta N, Sarkar M, Dodge JL, Fidelman N, Roberts JP, Yao FY
• Minimal Transplant Survival Benefit for Hepatocellular Carcinoma: Is it Real or an Overestimation of Waitlist Life Expectancy?
  Gastroenterology 2015 Mehta N, Heimbach J, Hirose R, Roberts JP, Yao FY
• Reassessing the boundaries of liver transplantation for hepatocellular carcinoma: Where do we stand with tumor down-staging?
  Hepatology (Baltimore, Md.) 2015 Yao FY, Fidelman N
• Liver transplantation for hepatocellular carcinoma: analysis of factors predicting outcome in 1074 patients in OPTN Region 5.
  Clinical transplantation 2015 Macdonald B, Sewell JL, Harper AM, Roberts JP, Yao FY
• Implications of discordant findings between hepatic angiography and cross-sectional imaging in transplant candidates with hepatocellular carcinoma.
  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2015 Young K, Fidelman N, Yao FY, Hills NK, Kohi MP, Kolli KP, Taylor AG, Kerlan RK
• Circulating tumor cells in hepatocellular carcinoma: a pilot study of detection, enumeration, and next-generation sequencing in cases and controls.
  BMC cancer 2015 Kelley RK, Magbanua MJ, Butler TM, Collisson EA, Hwang J, Sidiropoulos N, Evason K, McWhirter RM, Hameed B, Wayne EM, Yao FY, Venook AP, Park JW
• Downstaging of hepatocellular cancer before liver transplant: long-term outcome compared to tumors within Milan criteria.
  Hepatology (Baltimore, Md.) 2015 Yao FY, Mehta N, Flemming J, Dodge J, Hameed B, Fix O, Hirose R, Fidelman N, Kerlan RK, Roberts JP
• Potential role of the donor in hepatocellular carcinoma recurrence after liver transplantation.
  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2015 Vagefi PA, Dodge JL, Yao FY, Roberts JP
• Evaluating the validity of model for end-stage liver disease exception points for hepatocellular carcinoma patients with multiple nodules <2 cm.
  Clinical transplantation 2014 Samoylova ML, Dodge JL, Mehta N, Yao FY, Roberts JP
• Hepatic artery and biliary complications in liver transplant recipients undergoing pretransplant transarterial chemoembolization.
  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2014 Goel A, Mehta N, Guy J, Fidelman N, Yao F, Roberts J, Terrault N
• Response to letter to the editors.
  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2014 Yao FY, Hameed B, Mehta N, Roberts JP
• Combined effects of recipient age and model for end-stage liver disease score on liver transplantation outcomes.
  Transplantation 2014 Sharpton SR, Feng S, Hameed B, Yao F, Lai JC
• Restricting liver transplant recipients to younger donors does not increase the wait-list time or the dropout rate: the hepatitis C experience.
  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2014 Flemming JA, Vagefi PA, Freise CE, Yao FY, Terrault NA
• Alpha-fetoprotein level > 1000 ng/mL as an exclusion criterion for liver transplantation in patients with hepatocellular carcinoma meeting the Milan criteria.
  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2014 Hameed B, Mehta N, Sapisochin G, Roberts JP, Yao FY
• Time to transplantation as a predictor of hepatocellular carcinoma recurrence after liver transplantation.
  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2014 Samoylova ML, Dodge JL, Yao FY, Roberts JP
• Outcomes after liver transplantation for patients with hepatocellular carcinoma and a low risk of dropout from the transplant waiting list.
  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2014 Mehta N, Dodge JL, Roberts JP, Hirose R, Yao FY
• Conundrum of treatment for early-stage hepatocellular carcinoma: radiofrequency ablation instead of liver transplantation as the first-line treatment?
  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2014 Yao FY
• Identification of liver transplant candidates with hepatocellular carcinoma and a very low dropout risk: implications for the current organ allocation policy.
  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2013 Mehta N, Dodge JL, Goel A, Roberts JP, Hirose R, Yao FY
• Validating posttransplant hepatocellular carcinoma recurrence data in the United Network for Organ Sharing database.
  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2013 Samoylova ML, Dodge JL, Vittinghoff E, Yao FY, Roberts JP
• Moving past "One size (and number) fits all" in the selection of candidates with hepatocellular carcinoma for liver transplantation.
  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2013 Mehta N, Yao FY
• Reply: To PMID 23333661.
  Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2013 Yao F, Mehta N
• Factors associated with outcomes and response to therapy in patients with infiltrative hepatocellular carcinoma.
  Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2013 Mehta N, Fidelman N, Sarkar M, Yao FY
• Morbidity and mortality following transarterial liver chemoembolization in patients with hepatocellular carcinoma and synthetic hepatic dysfunction.
  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2012 Garwood ER, Fidelman N, Hoch SE, Kerlan RK, Yao FY
• Risk factors for liver transplant waitlist dropout in patients with hepatocellular carcinoma.
  Clinical transplantation 2012 Park SJ, Freise CE, Hirose R, Kerlan RK, Yao FY, Roberts JP, Vagefi PA
• Imaging predictors of the response to transarterial chemoembolization in patients with hepatocellular carcinoma: a radiological-pathological correlation.
  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2012 Kwan SW, Fidelman N, Ma E, Kerlan RK, Yao FY
• Multidisciplinary management of hepatocellular carcinoma.
  Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2011 Guy J, Kelley RK, Roberts J, Kerlan R, Yao F, Terrault N
• Does a patient qualify for liver transplantation after the down-staging of hepatocellular carcinoma?
  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2011 Yao FY, Breitenstein S, Broelsch CE, Dufour JF, Sherman M
• Do preoperative inflammatory markers impact on outcome after liver transplantation for hepatocellular carcinoma?
  Annals of surgery 2011 Sapisochin G, Yao FY, Roberts JP
• Mixed hepatocellular cholangiocarcinoma and intrahepatic cholangiocarcinoma in patients undergoing transplantation for hepatocellular carcinoma.
  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2011 Sapisochin G, Fidelman N, Roberts JP, Yao FY
• Cost-effectiveness of screening for recurrent hepatocellular carcinoma after liver transplantation.
  Clinical transplantation 2011 Ladabaum U, Cheng SL, Yao FY, Roberts JP
• Hepatocellular carcinoma: Ablate and wait versus rapid transplantation.
  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2010 Roberts JP, Venook A, Kerlan R, Yao F
• Excellent outcome following down-staging of hepatocellular carcinoma prior to liver transplantation: an intention-to-treat analysis.
  Hepatology (Baltimore, Md.) 2008 Yao FY, Kerlan RK, Hirose R, Davern TJ, Bass NM, Feng S, Peters M, Terrault N, Freise CE, Ascher NL, Roberts JP
• Liver transplantation for hepatocellular carcinoma: beyond the Milan criteria.
  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2008 Yao FY
• Current approach to down-staging of hepatocellular carcinoma prior to liver transplantation.
  Current opinion in organ transplantation 2008 Hanje AJ, Yao FY
• Liver transplantation for hepatocellular carcinoma.
  Annals of surgical oncology 2008 Mazzaferro V, Chun YS, Poon RT, Schwartz ME, Yao FY, Marsh JW, Bhoori S, Lee SG
• Liver transplantation at UCSF--a 20-year experience.
  Clinical transplants 2008 Hirose R, Yao F, Stock P, Roberts J, Ascher N
• Expanded criteria for liver transplantation in patients with hepatocellular carcinoma.
  Hepatology research : the official journal of the Japan Society of Hepatology 2007 Yao FY
• Liver transplantation for hepatocellular carcinoma: the hepatitis C quandary.
  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2007 Yao FY
• Should surveillance for hepatocellular carcinoma be increased in patients with cirrhosis and small liver nodules?
  Nature clinical practice. Gastroenterology & hepatology 2006 Yao FY
• De novo malignancies following liver transplantation: a case-control study with long-term follow-up.
  Clinical transplantation 2006 Yao FY, Gautam M, Palese C, Rebres R, Terrault N, Roberts JP, Peters MG
• Expanded criteria for hepatocellular carcinoma: down-staging with a view to liver transplantation--yes.
  Seminars in liver disease 2006 Yao FY
• Selection criteria for liver transplantation in patients with hepatocellular carcinoma: beyond tumor size and number?
  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2006 Yao FY
• A prospective study on downstaging of hepatocellular carcinoma prior to liver transplantation.
  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2005 Yao FY, Hirose R, LaBerge JM, Davern TJ, Bass NM, Kerlan RK, Merriman R, Feng S, Freise CE, Ascher NL, Roberts JP
• High incidence of recurrence and hematologic events following liver transplantation for Budd-Chiari syndrome.
  Clinical transplantation 2005 Cruz E, Ascher NL, Roberts JP, Bass NM, Yao FY
• The impact of pre-operative loco-regional therapy on outcome after liver transplantation for hepatocellular carcinoma.
  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2005 Yao FY, Kinkhabwala M, LaBerge JM, Bass NM, Brown R, Kerlan R, Venook A, Ascher NL, Emond JC, Roberts JP
• Cost-effectiveness of hepatocellular carcinoma surveillance in patients with hepatitis C virus-related cirrhosis.
  Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2005 Patel D, Terrault NA, Yao FY, Bass NM, Ladabaum U
• Applying expanded criteria to liver transplantation for hepatocellular carcinoma: too much too soon, or is now the time?
  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2004 Yao FY, Roberts JP
• Liver transplantation for hepatocellular carcinoma: lessons from the first year under the Model of End-Stage Liver Disease (MELD) organ allocation policy.
  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2004 Yao FY, Bass NM, Ascher NL, Roberts JP
• Prediction of survival after liver retransplantation for late graft failure based on preoperative prognostic scores.
  Hepatology (Baltimore, Md.) 2004 Yao FY, Saab S, Bass NM, Hirose R, Ly D, Terrault N, Lazar AA, Bacchetti P, Ascher NL, Roberts JP
• De novo non-alcoholic fatty liver disease following orthotopic liver transplantation.
  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2003 Poordad F, Gish R, Wakil A, Garcia-Kennedy R, Martin P, Yao FY
• A follow-up analysis of the pattern and predictors of dropout from the waiting list for liver transplantation in patients with hepatocellular carcinoma: implications for the current organ allocation policy.
  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2003 Yao FY, Bass NM, Nikolai B, Merriman R, Davern TJ, Kerlan R, Ascher NL, Roberts JP
• Dramatic reduction of the alpha-fetoprotein level after lamivudine treatment of patients with chronic hepatitis B virus infection and cirrhosis.
  Journal of clinical gastroenterology 2003 Yao FY